Brief: VBL Therapeutics Reports Full Year Loss Per Share Of $0.42

Notable Labs

14/03/2023 13:24

March 14 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VBL THERAPEUTICS REPORTS FULL YEAR 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
    * VASCULAR BIOGENICS LTD FY LOSS PER SHARE $0.42
    * VASCULAR BIOGENICS LTD - ON DECEMBER 31, 2022, VBL HAD
CASH,
CASH EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND RESTRICTED BANK
DEPOSITS OF $21.1 MILLION

Source text for Eikon:  ID:nGNX3GhQYM 
Further company coverage:  VBLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))